Literature DB >> 26718123

Downregulation of microRNA-206 suppresses clear cell renal carcinoma proliferation and invasion by targeting vascular endothelial growth factor A.

Yi Cai1, Hanzhong Li1, Yushi Zhang1.   

Abstract

MicroRNA-206 (miR-206) has been discovered to have anticancer properties in different tissues. However, the role of miR-206 on renal carcinoma is still ambiguous. In the present study, we investigated the role of miR-206 on the development of renal carcinoma. The results indicated that miR-206 was significantly downregulated in 69 clear cell renal carcinoma (ccRCC) tissues and low-level of miR-206 related to shorter metastasis-free survival time for patients with ccRCC. The results indicated that vascular endothelial growth factor A (VEGFA) was a direct target of miR-206 in renal cancer cells. Further studies revealed that upregulation of miR-206 inhibited renal cancer cell proliferation, invasion and migration, suggesting that miR-206 functioned as a tumor suppressor. RNA interference targeting VEGFA mRNA could mimic the upregulation of miR-206 functions, and also suppressed tumor formation in vivo in nude mice. These results suggest that miR-206 plays an important role in ccRCC tumorigenesis by targeting VEGFA.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26718123     DOI: 10.3892/or.2015.4538

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  12 in total

1.  MicroRNA-206 acts as a tumor suppressor in bladder cancer via targeting YRDC.

Authors:  Bisheng Huang; Wei Zhai; Guanghui Hu; Chi Huang; Tiancheng Xie; Jingwei Zhang; Yunfei Xu
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

2.  MicroRNA-138 attenuates epithelial-to-mesenchymal transition by targeting SOX4 in clear cell renal cell carcinoma.

Authors:  Feng Liu; Linfeng Wu; Anping Wang; Yajun Xu; Xiaodong Luo; Xing Liu; Yi Hua; Deying Zhang; Shengde Wu; Tao Lin; Dawei He; Guanghui Wei; Shanwen Chen
Journal:  Am J Transl Res       Date:  2017-08-15       Impact factor: 4.060

3.  miR-514a-3p functions as a tumor suppressor in renal cell carcinoma.

Authors:  Lu Jin; Yifan Li; Zeng Zhang; Tao He; Jia Hu; Jiaju Liu; Mingwei Chen; Yaoting Gui; Shangqi Yang; Xiangming Mao; Yun Chen; Yongqing Lai
Journal:  Oncol Lett       Date:  2017-08-31       Impact factor: 2.967

4.  miR-144 inhibits growth and metastasis of cervical cancer cells by targeting VEGFA and VEGFC.

Authors:  Pingping Tao; Hao Wen; Binlie Yang; Ai Zhang; Xiaohua Wu; Qing Li
Journal:  Exp Ther Med       Date:  2017-10-30       Impact factor: 2.447

5.  MiR-206 promotes extracellular matrix accumulation and relieves infantile hemangioma through targeted inhibition of DNMT3A.

Authors:  Minliang Wu; Yong Chen; Ling Feng; Haiying Dai; Shuo Fang; Jianguo Xu
Journal:  Cell Cycle       Date:  2021-05-04       Impact factor: 4.534

6.  MiR-206 Suppresses the Progression of Coronary Artery Disease by Modulating Vascular Endothelial Growth Factor (VEGF) Expression.

Authors:  Maojing Wang; Yang Ji; Shanglang Cai; Wei Ding
Journal:  Med Sci Monit       Date:  2016-12-20

7.  WISP-3 inhibition of miR-452 promotes VEGF-A expression in chondrosarcoma cells and induces endothelial progenitor cells angiogenesis.

Authors:  Chih-Yang Lin; Huey-En Tzeng; Te-Mao Li; Hsien-Te Chen; Yi Lee; Yi-Chen Yang; Shih-Wei Wang; Wei-Hung Yang; Chih-Hsin Tang
Journal:  Oncotarget       Date:  2017-06-13

8.  Silencing circZFR inhibits the proliferation, migration and invasion of human renal carcinoma cells by regulating miR-206.

Authors:  Mi Wang; Yisheng Gao; Jie Liu
Journal:  Onco Targets Ther       Date:  2019-09-13       Impact factor: 4.147

9.  miR-206 Promotes Cancer Progression by Targeting Full-Length Neurokinin-1 Receptor in Breast Cancer.

Authors:  Yu Zhou; Meng Wang; Yingna Tong; Xiaobin Liu; Lufang Zhang; Dong Dong; Jie Shao; Yunli Zhou
Journal:  Technol Cancer Res Treat       Date:  2019-01-01

10.  Downregulation of MicroRNA-206 Alleviates the Sublethal Oxidative Stress-Induced Premature Senescence and Dysfunction in Mesenchymal Stem Cells via Targeting Alpl.

Authors:  Xuan Liu; Ziying Yang; Qingyou Meng; Yueqiu Chen; Lianbo Shao; Jingjing Li; Yihuan Chen; Zhenya Shen
Journal:  Oxid Med Cell Longev       Date:  2020-02-13       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.